Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-047201
Filing Date
2025-03-31
Accepted
2025-03-31 07:16:02
Documents
85
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K caba-20241231.htm   iXBRL 10-K 3690642
2 EX-10.17 caba-ex10_17.htm EX-10.17 18111
3 EX-19.1 caba-ex19_1.htm EX-19.1 129410
4 EX-21.1 caba-ex21_1.htm EX-21.1 6131
5 EX-23.1 caba-ex23_1.htm EX-23.1 11071
6 EX-31.1 caba-ex31_1.htm EX-31.1 15737
7 EX-31.2 caba-ex31_2.htm EX-31.2 15840
8 EX-32.1 caba-ex32_1.htm EX-32.1 9544
9 EX-32.2 caba-ex32_2.htm EX-32.2 9537
10 GRAPHIC img63895535_0.jpg GRAPHIC 159052
11 GRAPHIC img63895535_1.jpg GRAPHIC 195555
12 GRAPHIC img63895535_2.jpg GRAPHIC 659219
  Complete submission text file 0000950170-25-047201.txt   14109495

Data Files

Seq Description Document Type Size
13 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT caba-20241231.xsd EX-101.SCH 1289464
88 EXTRACTED XBRL INSTANCE DOCUMENT caba-20241231_htm.xml XML 1824672
Mailing Address 2929 ARCH STREET SUITE 600 PHILADELPHIA PA 19104
Business Address 2929 ARCH STREET SUITE 600 PHILADELPHIA PA 19104 (267) 759-3100
Cabaletta Bio, Inc. (Filer) CIK: 0001759138 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39103 | Film No.: 25788880
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)